Avinash Rao Ullur, MD, FRCPC, DrNB, FASN, CHS (@TheBeaniac) header
Avinash Rao Ullur, MD, FRCPC, DrNB, FASN, CHS (@TheBeaniac) profile picture

Staff Internist and Nephrologist at YRH, Alumnus UofT & MPUH, Master's @Mcmaster's U #NSMC 2021🎓

Yarmouth, NS
Joined December 2018
Avinash Rao Ullur, MD, FRCPC, DrNB, FASN, CHS retweeted
This #WorldHypertensionDay, support accurate BP measurement, diagnosis, and evidence-based treatment in primary care. Hypertension Canada’s Primary Care Guideline offers practical recommendations for everyday practice. Read in CMAJ: cmaj.ca/content/197/20/E549 #Hypertension
1
1
110
Excellent discussion by Charmaine Lok on PISCES trial (on her birthday), evolved from the earlier FISH study. Despite positive findings of fish oil in cv outcomes, vascular access patency, FISH was viewed as a “negative”. @CSNSCN
1
1
5
388
Another key message from the PISCES trial journey was the importance of persistence and creative funding for investigator-led research, especially without industry sponsorship. PISCES ultimately demonstrated a HR of 0.57 for primary cardiovascular outcomes. #CSN2026 @CSNSCN
1
58
Important session by @ShaifaliSandal on disaster and emergency preparedness in kidney care. With increasing natural, human-caused, and infrastructure-related disasters globally, CKD patients face higher hospitalization risks & general population faces increased AKI risk. @CSNSCN
1
4
3
344
Kidney care systems need proactive disaster preparedness rather than reactive responses. Discussions on identifying structural and perception gaps, empowering communities in crisis management, and building system-level resiliency for the kidney community. @ShaifaliSandal @CSNSCN
1
1
3
164
Strong call for a national kidney disaster task force and dedicated clinical training pathways to improve emergency preparedness and coordinated responses for vulnerable kidney patients during disasters. @CSNSCN @ShaifaliSandal
4
81
Great connecting with an inspiring group of community nephrologists at CSNAGM 2026. Grateful for the shared learning, collaboration, and dedication toward improving kidney care across Canada. #CSN2026 @CSNSCN
1
1
243
Excellent discussions on Conservative Kidney Management (CKM) by Sara Davison. A key message: CKM should be individualized, with goals centered around quality of life than strict biochemical normalization. Practice patterns vary significantly across Canada. #CSN2026 @CSNSCN
1
1
1
212
Metabolic acidosis treatment and protein restriction in CKM showed limited benefit on mortality or CKD progression, while potentially worsening side effects, malnutrition, and sarcopenia. Focus should remain on individualized nutrition and patient preferences. @CSNSCN
1
1
1
73
Lisa Miller and Danielle Moorman reviewed CKM mineral bone disease management. Vitamin D, phosphate restriction, and phosphate binders showed limited outcome benefits and may negatively impact quality of life. Strong emphasis on individualized management @CSNSCN
3
3
472
Lunch symposium by Navdeep Tangri: powerful message: albuminuria is the gatekeeper of CKD progression, but CKD progression is no longer inevitable. With the right therapies, at the right time, in the right combinations, remission is increasingly achievable. #CSN2026 @CSNSCN
2
1
2
216
In the current era of available therapies, no patient with diabetic kidney disease should routinely progress to dialysis without optimized evidence-based treatment. A practical 4-step remission-focused approach to CKD care may change long-term outcomes. @CSNSCN
1
1
108
Vlado Perkovic - highlighting the evolving rx landscape aimed IgAN remission. Sibeprenlimab (APRIL inhibitor) & Atacicept (APRIL/BAFF inhibitor) - shown proteinuria reduction/remission results. Barrier is clinical inertia in timely diagnosis and rx escalation. @CSNSCN
1
156
Super fantastic Canadian onco-neph group at #CSN2026 (although we are missing a few others in the pic☺️) @CSNSCN @onconeph
1
1
8
2,000
Excellent session by Matt Oliver on optimizing peritoneal dialysis (PD) utilization. A key message: focus on true eligibility and avoid empirical contraindications that may unnecessarily limit PD uptake. #CSN2026 @CSNSCN
1
1
1
188
Important procedural insights as well: ~10% of patients with PD catheters never achieve effective PD, and by 6 months nearly 25% experience catheter-related complications — flow issues being the most common. @CSNSCN
1
29
Prior abdominal surgery alone may not significantly affect outcomes unless adhesions are present. Lower eGFR at initiation appears associated with higher catheter-related complications and “rocky starts.” #CSN2026 @CSNSCN
1
95
Excellent talk by Dorry Segev on AI in healthcare. Artificial neural networks help train AI through pattern recognition — AI is not “thinking” independently. Generative AI/LLMs fundamentally work by predicting the next word or thought based on learned patterns. @CSNSCN #CSN2026
1
1
1
187
Important perspective on where AI can realistically help nephrology: ambient documentation, clinic summaries, patient navigation, monitoring large follow-up populations for adverse events, integrating multimodal data for complex decisions, improving medication adherence @CSNSCN
1
1
28
AI still struggles with long complex histories and completeness of management — it needs to function as a partner in clinical care, not a replacement. @CSNSCN
19